Introduction

U.S. Senator Elizabeth Warren convened a meeting of MassMEDIC members, the FDA Commissioner, Dr. Margaret Hamburg and CDRH Director, Dr. Jeff Shuren on April 4 in Cambridge. The discussion centered on alternative pathways to market for novel technologies, use of OUS data in product submissions, retroactive application of guidance documents and consistency of reviewer training and management oversight.